Impaired neural development in a zebrafish model for Lowe syndrome
Impaired neural development in a zebrafish model for Lowe syndrome
Lowe syndrome, which is characterized by defects in the central nervous system, eyes and kidneys, is caused by mutation of the phosphoinositide 5-phosphatase OCRL1. The mechanisms by which loss of OCRL1 leads to the phenotypic manifestations of Lowe syndrome are currently unclear, in part, owing to the lack of an animal model that recapitulates the disease phenotype. Here, we describe a zebrafish model for Lowe syndrome using stable and transient suppression of OCRL1 expression. Deficiency of OCRL1, which is enriched in the brain, leads to neurological defects similar to those reported in Lowe syndrome patients, namely increased susceptibility to heat-induced seizures and cystic brain lesions. In OCRL1-deficient embryos, Akt signalling is reduced and there is both increased apoptosis and reduced proliferation, most strikingly in the neural tissue. Rescue experiments indicate that catalytic activity and binding to the vesicle coat protein clathrin are essential for OCRL1 function in these processes. Our results indicate a novel role for OCRL1 in neural development, and support a model whereby dysregulation of phosphoinositide metabolism and clathrin-mediated membrane traffic leads to the neurological symptoms of Lowe syndrome.
Animals, Brain/embryology, Cell Survival, Clathrin/metabolism, Disease Models, Animal, Embryo, Nonmammalian, Embryonic Development, Endosomes/metabolism, Gene Expression Profiling, Golgi Apparatus/metabolism, Hot Temperature, Oculocerebrorenal Syndrome, Phosphatidylinositol 4,5-Diphosphate/metabolism, Phosphoric Monoester Hydrolases/genetics, Protein Splicing, Proto-Oncogene Proteins c-akt/metabolism, Seizures/physiopathology, Signal Transduction, Zebrafish/embryology, Zebrafish Proteins/genetics
1744-59
Ramirez, Irene Barinaga-Rementeria
a4971a52-9ace-430a-a403-858d9fc683c7
Pietka, Grzegorz
9aa4fa98-3a38-475b-a709-3b646bc68078
Jones, David R
b8f3e32c-d537-445a-a1e4-7436f472e160
Divecha, Nullin
5c2ad0f8-4ce7-405f-8a15-2fc4ab96d787
Alia, A
de91304c-b788-4284-8678-42d8d5fd1b3e
Baraban, Scott C
cb63bb66-c15d-49ef-8cd3-8e337e6837dd
Hurlstone, Adam F L
e45ddbb2-f33a-4195-890e-551fb292c1ff
Lowe, Martin
9a9dfb7a-8e2b-46ce-b649-4d0bfdae1ceb
30 December 2011
Ramirez, Irene Barinaga-Rementeria
a4971a52-9ace-430a-a403-858d9fc683c7
Pietka, Grzegorz
9aa4fa98-3a38-475b-a709-3b646bc68078
Jones, David R
b8f3e32c-d537-445a-a1e4-7436f472e160
Divecha, Nullin
5c2ad0f8-4ce7-405f-8a15-2fc4ab96d787
Alia, A
de91304c-b788-4284-8678-42d8d5fd1b3e
Baraban, Scott C
cb63bb66-c15d-49ef-8cd3-8e337e6837dd
Hurlstone, Adam F L
e45ddbb2-f33a-4195-890e-551fb292c1ff
Lowe, Martin
9a9dfb7a-8e2b-46ce-b649-4d0bfdae1ceb
Ramirez, Irene Barinaga-Rementeria, Pietka, Grzegorz, Jones, David R, Divecha, Nullin, Alia, A, Baraban, Scott C, Hurlstone, Adam F L and Lowe, Martin
(2011)
Impaired neural development in a zebrafish model for Lowe syndrome.
Human Molecular Genetics, 21 (8), .
(doi:10.1093/hmg/ddr608).
Abstract
Lowe syndrome, which is characterized by defects in the central nervous system, eyes and kidneys, is caused by mutation of the phosphoinositide 5-phosphatase OCRL1. The mechanisms by which loss of OCRL1 leads to the phenotypic manifestations of Lowe syndrome are currently unclear, in part, owing to the lack of an animal model that recapitulates the disease phenotype. Here, we describe a zebrafish model for Lowe syndrome using stable and transient suppression of OCRL1 expression. Deficiency of OCRL1, which is enriched in the brain, leads to neurological defects similar to those reported in Lowe syndrome patients, namely increased susceptibility to heat-induced seizures and cystic brain lesions. In OCRL1-deficient embryos, Akt signalling is reduced and there is both increased apoptosis and reduced proliferation, most strikingly in the neural tissue. Rescue experiments indicate that catalytic activity and binding to the vesicle coat protein clathrin are essential for OCRL1 function in these processes. Our results indicate a novel role for OCRL1 in neural development, and support a model whereby dysregulation of phosphoinositide metabolism and clathrin-mediated membrane traffic leads to the neurological symptoms of Lowe syndrome.
This record has no associated files available for download.
More information
Accepted/In Press date: 21 December 2011
Published date: 30 December 2011
Additional Information:
This work was funded by a Wellcome Trust project grant (079615) and a research grant from the UK Lowe Syndrome Trust (ML/MU/DEC07) awarded to M.L. A.H. was supported by a Cancer Research UK Career Development Fellowship. Funding to pay the Open Access publication charges for this article was provided by the Wellcome Trust.
Keywords:
Animals, Brain/embryology, Cell Survival, Clathrin/metabolism, Disease Models, Animal, Embryo, Nonmammalian, Embryonic Development, Endosomes/metabolism, Gene Expression Profiling, Golgi Apparatus/metabolism, Hot Temperature, Oculocerebrorenal Syndrome, Phosphatidylinositol 4,5-Diphosphate/metabolism, Phosphoric Monoester Hydrolases/genetics, Protein Splicing, Proto-Oncogene Proteins c-akt/metabolism, Seizures/physiopathology, Signal Transduction, Zebrafish/embryology, Zebrafish Proteins/genetics
Identifiers
Local EPrints ID: 479701
URI: http://eprints.soton.ac.uk/id/eprint/479701
ISSN: 0964-6906
PURE UUID: fdec7176-4bed-4f6b-8b5a-e196fb693f11
Catalogue record
Date deposited: 26 Jul 2023 16:49
Last modified: 18 Mar 2024 02:50
Export record
Altmetrics
Contributors
Author:
Irene Barinaga-Rementeria Ramirez
Author:
Grzegorz Pietka
Author:
A Alia
Author:
Scott C Baraban
Author:
Adam F L Hurlstone
Author:
Martin Lowe
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics